HAEM5:Volunteer Assignments and Opportunities: Difference between revisions
| [checked revision] | [checked revision] |
No edit summary |
No edit summary |
||
| Line 386: | Line 386: | ||
|[[HAEM5:Acute myeloid leukaemia with BCR::ABL1 fusion|Acute myeloid leukaemia with BCR::ABL1 fusion]] | |[[HAEM5:Acute myeloid leukaemia with BCR::ABL1 fusion|Acute myeloid leukaemia with BCR::ABL1 fusion]] | ||
|Disease | |Disease | ||
|Xinxiu Xu (trainee) | |(Xinxiu Xu)(trainee) Malini Sathanoori, Ph.D. | ||
| | |4/15/25 | ||
| | | | ||
| | | | ||
| Line 467: | Line 467: | ||
|[[HAEM5:Acute myeloid leukaemia with CEBPA mutation|Acute myeloid leukaemia with CEBPA mutation]] | |[[HAEM5:Acute myeloid leukaemia with CEBPA mutation|Acute myeloid leukaemia with CEBPA mutation]] | ||
|Disease | |Disease | ||
|Xinxiu Xu (trainee) | |(Xinxiu Xu)(trainee) Malini Sathanoori, Ph.D. | ||
| | |4/15/25 | ||
| | | | ||
| | | | ||
| Line 727: | Line 727: | ||
|[[HAEM5:Myeloid neoplasms associated with germline predisposition|Myeloid neoplasms associated with germline predisposition]] | |[[HAEM5:Myeloid neoplasms associated with germline predisposition|Myeloid neoplasms associated with germline predisposition]] | ||
|Disease | |Disease | ||
| | |Malini Sathanoori, Ph.D. | ||
| | | | ||
| | | | ||